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HIV-Tat induces a decrease in I Kr and I Ks via reduction in phosphatidylinositol-(4,5)-bisphosphate availability
INTRODUCTION
As a consequence of the development of antiretroviral therapies (ART), life expectancy of HIV-positive individuals has greatly increased. For this population, excess mortality is moderate in industrialized countries and comparable with populations having other chronic conditions [1] . Life expectancy of HIV-positive individuals has also increased in middle income countries, gaining for instance 10 years between 2004 and 2011 in South Africa [2] .
Worldwide, the increasing access of patients to ART, from 31% in 2008 to 36% in 2014 [3, 4] leads to further increase in aging HIV-positive individuals. This aging population faces additional pathologies that are over-represented as compared to the general population. This is pointed out by a study on sudden cardiac death (SCD) in HIV positive individuals, showing a mean SCD rate 4.5 fold higher than in the general population [5] . Furthermore, up to 20% of the HIV patients are presenting with a long QT syndrome (LQTS), a greater prevalence than in the general population; prolonged QT interval is a risk factor for malignant arrhythmia [5] [6] [7] [8] . However, the mechanistic link between LQTS and HIV remains unidentified.
Many drugs and combinations of drugs may be potential triggers of LQTS through inhibition of a major cardiac repolarizing current, I Kr , conducted by the voltage-gated potassium channel hERG [9] . Among them, numerous drugs currently prescribed to HIV-positive individuals have been associated with a QT prolongation, such as macrolides, pentamidine, azole antifungals, fluoroquinolones [10] and methadone [11] . On the other hand, QT prolongation on ECGs of HIV-positive individuals is correlated to the duration of HIV infection rather than the anti-HIV treatment [12] . Moreover, QT prolongation is observed in HIV-positive individuals under no medication recognized to prolong QT [13] , suggesting a role for the virus itself in inducing LQTS. In addition, several studies using animal models suggest a rather direct implication of HIV in LQTS. For instance, prolonged cardiac repolarization and decreased repolarizing potassium currents were observed in mice expressing the whole HIV-1 genome [14, 15] .
Among the ~15 proteins encoded by the virus, Tat appears as a potential candidate for inducing ventricular arrhythmias, as it prolongs the action potential of guinea-pig ventricular cardiomyocytes through a reduction in the hERG-related current, I Kr [16] . Noteworthy, serum levels of Tat remain high in treated patients, which could explain the high prevalence in prolonged QT interval despite antiretroviral therapies [12, 17] . Among the documented properties of Tat in cells, it was shown that its affinity for phosphatidylinositol-(4,5)-bisphosphate (PIP 2 ) is very high, the dissociation constant (K d ) being in the low nanomolar 4 range [18] . QT prolongation is majorly associated with the inhibition of two major cardiac delayed rectifier potassium currents: I Ks and I Kr , respectively carried by KCNQ1 channels associated with the regulatory subunit KCNE1 and hERG channels [19] . Interestingly enough, both KCNQ1 and hERG are positively regulated by PIP 2 [20, 21] . We thus hypothesized that Tat inhibits these channels by sequestering membrane PIP 2 , leading to long QT syndrome in HIV patients.
In order to test this hypothesis, we evaluated the effect of Tat on cells expressing KCNQ1 or hERG channels. Tat over-expression led to a decrease in hERG and KCNE1-KCNQ1 currents and modification of their biophysical parameters, in particular an acceleration of deactivation.
A mutant Tat with a profound decrease in PIP 2 affinity has no effect on these current and WTTat has no effect on a PIP 2 insensitive mutant KCNQ1 channel, consistent with Tat acting through a reduction in available PIP 2 . In human cardiomyocytes derived from induced pluripotent stem cells, 24-h Tat incubation led to a decrease in cardiac I Kr and acceleration of its deactivation, and these effects were associated with a prolongation of the action potential duration. Altogether, these observations suggest that in HIV-positive individuals, Tat sequesters PIP 2 , leading to a decrease in I Kr and I Ks currents, providing a basis for QT prolongation. 
MATERIALS AND METHODS
Tat protein preparation
Recombinant Tat was purified from Escherichia coli as previously described [22] , resuspended as a 200 µg/ml stock solution in citrate buffer (110 mM sodium chloride, 30 mM sodium citrate, 20 mM sodium phosphate, pH 7.3), and stored at -80°C. BCA protein assay (Pierce) was used to measure Tat protein concentration. Tat transactivation activity was confirmed as previously described [23] . Briefly, COS-7 cells were cultured in 24-well plates and cotransfected using FuGENE 6 (Promega) with 0.22 µg/well pGL3-LTR, encoding firefly luciferase under the control of Tat-activated HIV-1-LTR promoter, and 1.78 µg/well pRL-TK (Promega), encoding Renilla luciferase under the control of Herpes simplex virus thymidine kinase promoter, to normalize the results. After 24 h, 2.3 µg/ml recombinant Tat (or the citrate buffer) and 100 µM chloroquine (for Tat uptake) were added. One day later, cells were lysed for determination of dual firefly/Renilla luciferase activity ratio (Supplemental figure   1 ). Twenty-four hours before patch-clamp measurements and immunofluorescence assays, Tat was diluted and cells were incubated at concentrations of 200 ng/ml (~20 nM) or 400 ng/ml (~40 nM), consistent with patient serum levels [17] .
Supplemental figure 1:
Tat protein is active in COS-7 cells. Firefly/Renilla luciferase activity ratio in luciferase-transfected COS-7 cells, either untreated (Buffer) or incubated with WT-Tat (Tat), in presence of chloroquine. Firefly luciferase expression is driven by a Tatdependent promoter while Renilla luciferase expression is insensitive to the presence of Tat and serves as an internal control. 
Cell culture and transfection
HEK293 cells stably expressing hERG (HEK-hERG; CreaCell; protein accession number: NP_000229.1) and COS-7 cells (American Type Culture Collection) were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal calf serum (Eurobio) and antibiotics (100 IU/ml penicillin and 100 μg/ml streptomycin; Gibco) at 5% CO 2 and 37°C in a humidified incubator. For HEK-hERG cells, hERG expression was maintained by the application of the selection antibiotic G418 (1200 µg/ml; Life Technologies).
When reaching 60-80% cell confluence, COS-7 cells were transiently transfected in 35-mm plates with 2 μg of total DNA (as described below) complexed with FuGENE 6. For Tat and KCNE1-KCNQ1 co-transfection experiments, the ionic currents were obtained from a fusion In the latter case, medium was renewed 8 h before cells were split. For Tat incubation experiments, Tat or citrate buffer diluted in culture medium were applied 4-6 hours after cells splitting and treated cells were incubated at 37°C. Experiments were performed the day after cell splitting.
Culture of human induced pluripotent stem cells
The previously characterized foreskin fibroblast-derived human induced pluripotent stem (hiPS) cell clone C2a was used [24] . The hiPS cell line was maintained on mitoticallyinactivated MEFs in DMEM/F12 medium supplemented with 2 mM L-glutamine, 0.07% β-mercaptoethanol, 20% knockout serum replacement, 5 ng/ml bFGF and 1% NEAA under low 7 oxygen atmosphere (4% O 2 ). Cells were passaged by manual dissection of cell clusters every 6 to 7 days. Before cardiac differentiation, hiPS cells were manually transferred from MEFs to hESC-qualified matrigel-coated plates (0.05 mg/ml, BD Biosciences) and cultured in StemMACS (iPS-Brew XF) medium (Miltenyi Biotec). Passages were performed using Gentle Cell Dissociation Buffer (StemCell Technologies).
Differentiation of hiPS cells into cardiomyocytes and dissociation
Human iPS cells were differentiated into cardiomyocytes using the Matrix sandwich method, as previously described [25, 26] . Cardiomyocytes derived from hiPS cells (hiPS-CMs) were duration, maximum upstroke velocity (dV/dt max ), peak to peak duration, amplitude (mV) and maximum diastolic potential, as previously defined [26] .
For currents recording, the ruptured-patch configuration was used. Hz) followed by a repolarization to the holding potential at -80 mV. Inactivation was studied with a two-pulse protocol: a 3-s depolarization to potentials ranging from -65 to -5 mV was followed by a 400-ms depolarization to 0 mV where the peak current was measured (holding potential: -50 mV, 0.125 Hz).
2.7.I KATP recordings in mouse neonatal cardiomyocytes
Single cell suspensions from 1-2 day-old mouse neonatal hearts were prepared in a semiautomated procedure by using the Neonatal Heart Dissociation kit and the gentleMACS TM Dissociator. Hearts were first excised from the mice then the ventricles were separated from the atrium. After gentleMACS TM dissociation, the cell supernatant was removed by centrifugation and the pellet was resuspended in culture medium containing Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% horse serum, 5% fetal bovine After patch rupture, the outward current increased gradually due to dilution of cytosolic ATP into the pipette. When the current reached steady state, glibenclamide was added to the external solution to block the I KATP current. A ramp protocol was used to monitor the current decrease upon glibenclamide application. From a holding potential of -70 mV, a 20 ms step to -110 mV was applied followed by a 500 ms ramp from -110 to +40 mV (stimulation frequency, 0.2 Hz). A step protocol was applied before and after glibenclamide application to measure the glibenclamide-sensitive current.
Tat immunofluorescence
Two types of histological analyses were performed, (1) 
mRNA and Protein expression analysis
For gene expression analysis, total RNA was extracted and reverse transcribed, from hiPSCMs and HEK-hERG cells, as previously described [26] . PCR amplification was performed 11 using FAM-labeled TaqMan probes: ACTB (Hs99999903_m1), KCNH2 (Hs04234270-g1)
and Troponin I (Hs00165957-m1).
For Western blot analysis, 60 µg of protein lysate from hiPS-CMs or 10 µg of protein lysate from HEK-hERG, both treated for 24 h with 200 ng/ml Tat or buffer were incubated with mouse antisera against hERG protein (Santa Cruz). Secondary antibody staining was performed using goat anti-mouse IgG-HRP antibody (Santa Cruz). Stain Free gel technology (Bio-Rad) was used as loading control for protein normalization: the amount of total proteins in each lane of the blot was calculated and used for normalization [29, 30] .
Data analysis
Steady-state activation and inactivation curves were fitted with a single Boltzmann function 
RESULTS
Tat transfection leads to a decrease in hERG and KCNE1-KCNQ1 currents and acceleration of deactivation, consistent with a decrease in PIP 2 availability
We first evaluated the effects of Tat co-expression with hERG or KCNQ1 fused to KCNE1
(KCNE1-KCNQ1) in COS-7 cells. This set of experiments allowed us to compare the effects of WT-Tat with those of W11Y-Tat, which presents a profoundly reduced PIP 2 affinity, although having a normal transactivation activity [18] . In contrast with WT-Tat, this mutant cannot enter the cells and thus, testing the effects of its intracellular application requires its transfection. Figure 1A shows representative hERG current recordings in cells co-transfected with GFP, WT-Tat, or W11Y-Tat. I hERG density was reduced in presence of WT-Tat as compared to GFP. In order to test whether this is due to a reduction in PIP 2 availability, we evaluated the effects of the W11Y-Tat. Consistent with the hypothesis, we did not observe any alteration of the hERG current. It was shown that a decrease in PIP 2 leads to a
destabilization of hERG open state, provoking a reduction in the current amplitude and an acceleration in channel deactivation without any shift of the activation curve to positive potentials [21] . In accordance with a PIP 2 -reduction effect, WT-Tat and not W11Y-Tat led to the same changes in current density and deactivation without any shift in the activation curve ( Figure 1B -D, Table 1 ). These data suggest that Tat inhibits hERG by sequestering PIP 2 .
For KCNE1-KCNQ1 also, a decrease in PIP 2 availability leads to a decrease in current density and an acceleration of deactivation [20] . Again, WT-Tat but not W11Y-Tat led to the same effects as when the channel interaction with PIP 2 is altered ( Figure 1E -H, Table 1 ). To confirm the hypothesis that Tat reduces the current amplitude of delayed rectifier currents through a decrease in available PIP 2 , we tested the effect of Tat on the mutant KCNE1-R539W-KCNQ1 channel that is insensitive to PIP 2 depletion, when triggered by wortmannin application or by CiVSP phosphatase activation [31] . We compared current amplitude in cells expressing KCNE1-R539W-KCNQ1 in the absence and presence of Tat ( Figure 2 ). As opposed to WT KCNE1-KCNQ1, Tat expression did not affect KCNE1-R539W-KCNQ1 current amplitude measured after channel full activation, reinforcing the interpretation that
Tat decreases KCNE1-KCNQ1 channel activity through a decrease in available PIP 2 .
Altogether, these data strongly suggest that Tat inhibits hERG and KCNE1-KCNQ1 currents by sequestering PIP 2 . Current densities differences were statistically evaluated using a Mann-Whitney test, hERG τ deact using a two-way ANOVA for repeated measurements, and KCNE1-KCNQ1 τ deact at -40 mV using Student t-test. * p < 0.05; for WT-Tat vs GFP. # p < 0.05; ## p < 0.01; ### p < 0.001 for W11Y-Tat vs WT-Tat. § p < 0.05. Current densities differences were statistically evaluated using a Mann-Whitney test. ** p < 0.01.
15
To localize Tat, immunofluorescence assays were performed using the same conditions as for patch-clamp experiments, i.e. cotransfection of hERG with either WT-or W11Y-Tat/GFP bidirectional plasmids. They confirmed that WT-Tat localizes at the COS-7 plasma membrane, through its interaction with PIP 2 [32] . Unlike WT-Tat, W11Y-Tat localized diffusely in the cytosol, its lack of affinity for PIP 2 preventing its plasma membrane localization ( Figure 3A & B) . This is consistent with the absence of W11Y-Tat effect on PIP 2 -dependent channels activity. 
Tat incubation does not alter hERG and KCNE1-KCNQ1 currents in heterologous expression systems
In HIV patients, T-cells-secreted Tat can enter multiple cell types, through the interaction with various ubiquitous receptors [18] . We thus tested the effect of Tat applied externally on hERG and KCNE1-KCNQ1 channels activity. We first studied the effect of Tat 24-h incubation in HEK293 cells stably expressing hERG channels. We chose a 24-h incubation since in the different biological assays in which Tat had been tested (neurosecretion [32] and phagocytosis [33] ), it was found to require some time (3-4 hours) for Tat, after initial internalization, to accumulate on PIP 2 and to perturb processes relying on this phosphoinositide. Moreover such a 24-h incubation, and not acute application, had already been associated with a decrease in hERG current density in this model [16] . Surprisingly and figure 2C, E & F) . In addition, neither mRNA nor total hERG protein levels were affected (Supplemental figure 2G & H) . Tat entry into cells occurs through receptors of which expression vary from one cell type to another [34] . The observed absence of Tat effect may then be due to insufficient penetration into HEK cells. In order to evaluate whether the cell type could explain the absence of incubated Tat effect on I hERG , this analysis was repeated in COS-7 cells transiently expressing hERG (Supplemental figure 3) .
Again 200 ng/ml Tat incubation did not lead to any change in either hERG current density or biophysical parameters. In addition, we did not observe any effect of Tat incubation on KCNE1-KCNQ1 channel activity in COS-7 cells (Supplemental figure 4) . 
Supplemental
Tat incubation decreases I Kr in cardiomyocytes derived from human induced pluripotent stem cells
Cardiomyocytes differentiated from hiPS cells provided us with the opportunity to evaluate the effect of Tat incubation on a more relevant cellular model than non-cardiac cells. As shown in figure 4A & B, I Kr , isolated as the E-4031-sensitive current, was significantly reduced in hiPS-CMs incubated for 24 h with 200 ng/ml Tat. After full activation, the maximum tail E-4031-sensitive current density measured at -50 mV was reduced by 31%
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( Figure 4B ; Table 2 ; p < 0.05). In addition, no detectable I Ks was observed after E-4031-application. Thus, activation curve and deactivation kinetics were measured using the total K + tail current. The activation curve was not modified but the current deactivation was accelerated (Figure 4C & D; Table 2 Since Tat also affects transfected KCNE1-KCNQ1, which is related to the cardiac I Ks current, we set out to study the effect of Tat on I Ks in native tissue. However, in our model of cardiomyocytes differentiated from hiPS cells, we did no observe any tail current in presence of 1 µM E-4031 (not shown), suggesting that KCNE1 and/or KCNQ1 subunits are not expressed/functional in this model. We also applied 1 µM epinephrine to enhance this current [35, 36] but again, no tail was observed in 1 µM E-4031. 
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In addition to hERG and KCNQ1, PIP 2 has been shown to modulate the activity of a plethora of ion channels [37] , yet it is possible that many of these channels are not affected by PIP 2 if variations are limited to its physio/pathophysiological range [38] . To address this issue, we tested the effect of Tat on several channels suggested to be regulated by PIP 2 . PIP 2 has previously been shown to modulate the L-type Ca 2+ current, I Ca,L , in neurons and in natural killer cells [39, 40] and Ca V 1.2 and Ca V 1.3 in heterologous expression system [41] . We investigated Tat effects on the L-type Ca 2+ current in hiPS-CMs. Tat incubation did not modify I Ca,L density or biophysical properties (Figure 6 ), showing that endogenous Ca 2+ channels activity is not affected by Tat in hiPS-CMs. This observation suggests that hiPS-CM Ca 2+ channels are not as sensitive as hERG to a decrease in available PIP 2 . 
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In order to evaluate if Tat also alters the activity of an inward rectifier channel, we chose a channel which has a low apparent affinity to PIP 2 . Such channel, which is less stabilized by PIP 2 is more prone to a decrease in activity when available PIP 2 is decreased [42] . Thus we selected the K ATP channel, since the alpha-subunit of this channel, Kir6.2, has a low affinity to PIP 2 and is more prone to be sensitive toTat [42] . As no K ATP current was detected in the hiPS-CMs as a glibenclamide-sensitive outward current measured at +40 mV, we used neonatal mouse cardiomyocytes, in which a 24 h incubation with 200 ng/ml Tat led to a decrease in the K ATP current (Supplemental figure 5) . This suggests that Tat may lead to a remodeling of the electrical activity of cardiomyocytes through an alteration of the activity of several PIP 2 -sensitive channels. 
Tat related reduction of I Kr is not due to a reduction in membrane hERG
Since Tat has been shown to interfere with protein expression in host cells [43] , it may also act on hERG through a reduction in its expression. To test whether Tat directly alters expression of native hERG in hiPS-CMs, we performed qRT-PCR and western blot analyses.
While no reduction of hERG mRNA was observed, total hERG protein amount was reduced by about 20% only (Figure 4 E & F) . Moreover, the mature (i.e. glycosylated) fraction responsible for the K + current [44] , was not significantly reduced ( Figure 4F ), suggesting that 26 inhibition of hERG protein expression is not responsible for hERG current decrease and that in cardiomyocytes, Tat incubation mostly affects hERG gating.
Tat modifies the electrical activity of cardiomyocytes derived from human induced pluripotent stem cells
Action potentials (APs) were then recorded using the permeabilized patch configuration in hiPS-CMs. Three types of AP shapes were obtained and categorized as nodal-, atrial-, and ventricular-like APs (Table 3 ). Since LQTS is associated with ventricular AP prolongation, we focused on ventricular-like APs paced at two cycle lengths. As illustrated in Figure 7A , APs were prolonged in hiPS-CMs incubated for 24 h with 200 ng/ml Tat. Only APD 70 and APD 90 were prolonged as expected with hERG inhibition (p < 0.05; Figure 7B ). In addition, most Tat-incubated cells showed a higher APD 90 dispersion compared to cells incubated with buffer ( Figure 8 ). This dispersion resulted from AP duration and amplitude alternans ( Figure   8A ). APD 90 alternans were exacerbated at faster stimulation rates (shorter PCLs; Figure 8B ). [18] . Knowing that hERG and KCNQ1 currents are modulated by membrane PIP 2 levels, we tested whether Tat can affect those currents by sequestering PIP 2 . Co-transfecting Tat with either channel led to modification of the biophysical parameters in accordance with a decrease in available PIP 2 . Moreover, the W11Y-Tat mutant, which is 300 times less affine for PIP 2 [18] , has no effect on the activity of both channels. Importantly, W11Y-Tat mutation does not alter its native transactivation activity [23] , suggesting that loss of effect of W11Y-Tat on hERG and KCNE1-KCNQ1 channels activity is rather due to the disrupted interaction with [38] . This work enlightens a pathophysiological condition where I Kr is indeed reduced through a decrease in available PIP 2 . We also show that other PIP 2 -sentitive channels, such as the K ATP channel [45] may also be affected. Since this channel is implicated in the ischemic preconditioning, this could explain at least partly the increase in acute myocardial infarction in HIV-patients adjusted for hypertension, diabetes, and dyslipidemia [46] . In human cardiomyocytes, we did not observe any effect of Tat incubation on the transient calcium current I CaL , despite its described PIP 2 sensitivity [41] . This observation supports the hypothesis that channel activity is differentially modulated depending on its affinity for PIP 2 [47] . [50] in which I Ks presents a much larger contribution to the repolarizing currents without any adrenergic stimulus.
Bai and collaborators did observe an effect of Tat incubation on hERG current amplitude in a similar HEK293 model as we used [16] . However, these authors used a short isoform of Tat encoded by the first exon of the protein only (72 residues; Tat-72). The Tat protein used in our study is a 86 residues long (Tat-86), two-exon form of Tat that is present in viral isolates [34] . Although both Tat-72 and Tat-86 contain the transactivation domain, and are frequently used for in vitro studies, Tat-86 is more readily taken up than Tat-72 by various cell types [51] . In addition, the second exon endows Tat with additional activities and is critical for both in vitro and in vivo HIV replication [52] . Therefore, the use of Tat-86 appears to be more relevant to evaluate HIV impact on human cardiomyocyte electrical activity.
In LQT patients, T-wave alternans mirroring ventricular AP alternans are associated with delayed repolarization and are a known risk factor for sudden death [53] . In hiPS-derived cardiomyocytes, Tat incubation resulted in a significant reduction in I Kr current, associated with ventricular AP prolongation, as would be expected, and alternans occurrence. Up to now, such human AP alterations could be addressed with in silico studies only. For example, similar AP prolongation at low rate and APD alternans at elevated rate were observed when I Kr alterations due to a human LQT-related hERG mutation were implemented in a mathematical model of the human ventricular action potential [54] . Similarly, mild reduction in repolarization reserve due to alteration of I Kr parameters led to APD alternans using another in silico model [55] . These results are also in agreement with the observations in canine cardiomyocytes of AP alternans suppression by overexpression of hERG [56] . However, in silico or animal models are limited to investigate the potential multiple effects of actors such as Tat on their various mechanistic targets, in a situation far more complex than a single mutation.
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In conclusion, this study strongly suggests that PIP 2 is the link between HIV-Tat and the cardiac arrhythmias observed in HIV-positive individuals. In neurosecretory cells, it has been proposed that Tat perturbs the recruitment of several PIP 2 -dependent key players of the exocytotic machinery [32] . Combined with this previous investigation, our work suggests a general remodeling of PIP 2 -dependent processes by HIV via Tat. It would be interesting to test whether other processes, immune or not immune, are also affected by Tat through PIP 2 . 
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